ASC 275-10
Overall
275 Risks and Uncertainties
Source downloaded: .Record version 199e45e55700. Effective date must be checked in the source.
In brief
IntermediateDisclosureFinancial statement presentationContingencies and guaranteesPresentationASC 275-10 requires all entities to disclose, in the basic financial statements, information about risks and uncertainties existing at the balance sheet date in four areas: nature of operations (or, if principal operations have not commenced, current activities), the pervasive use of management estimates, certain significant estimates, and current vulnerability due to certain concentrations (275-10-50-1). The hallmark of the Subtopic is selectivity — disclosure is triggered only when specified screening criteria are met, generally when it is at least reasonably possible that a change or severe impact will occur in the near term and the effect would be material or severe (275-10-50-8; 275-10-50-16). It excludes risks from management/key personnel, proposed regulatory or accounting changes, internal control deficiencies, and acts of God, war, or sudden catastrophes (275-10-15-4).
Key points (7)
- Four required disclosure areas, all in the basic financial statements: nature of operations (including activities if principal operations have not commenced), use of estimates, certain significant estimates, and current vulnerability due to certain concentrations (275-10-50-1).
- Nature of operations disclosure must describe major products/services, principal markets and their locations, and, if the entity operates in more than one business, the relative importance of each and the basis (assets, revenues, or earnings); it need not be quantified (275-10-50-2), and an entity that has not commenced principal operations describes its current activities and what they are directed toward (275-10-50-2A).
- Financial statements must include an explanation that preparation under GAAP requires the use of management's estimates (275-10-50-4; illustrated at 275-10-55-6).
- A significant estimate must be disclosed when known information available before issuance indicates both that (a) it is at least reasonably possible the estimate of the effect of a condition existing at the balance sheet date will change in the near term due to future confirming events and (b) the effect of the change would be material (275-10-50-8); the disclosure states the nature of the uncertainty and the near-term reasonable possibility, and for Topic 450 loss contingencies also an estimate of possible loss or range or a statement that none can be made (275-10-50-9).
- Disclosure of a significant estimate does not depend on the amount recognized — a small or zero recorded amount does not excuse disclosure if a different estimate would have had a material effect (275-10-50-14); examples of sensitive estimates are listed at 275-10-50-15.
- Concentrations described in 275-10-50-18 (customer/supplier/lender/grantor/contributor volume; revenue from particular products, services or fund-raising events; sources of supply, labor, licenses; market or geographic area) must be disclosed if the concentration exists at the balance sheet date, makes the entity vulnerable to a near-term severe impact, and it is at least reasonably possible the triggering events will occur in the near term (275-10-50-16); loss of a customer, grantor, or contributor and disruption of operations outside the home country are always deemed at least reasonably possible.
- Specific quantitative disclosures are required for labor subject to collective bargaining agreements (percentage of labor force covered and percentage expiring within one year) and for operations outside the home country (carrying amounts of net assets and geographic areas) (275-10-50-20).
For students. This is the source of the boilerplate "use of estimates" note and concentration-of-credit/customer disclosures you see in almost every set of financial statements; the common mistake is assuming a small or zero recorded balance excuses disclosure (275-10-50-14) or confusing ASC 275's near-term "reasonably possible change in estimate" trigger with ASC 450's loss-contingency trigger — the two are separate and additive.
Machine-generated study aid for ASC 275-10. Check the source paragraphs below.
275-10-00Status
Source downloaded: .Record version 98eac33ae344. Effective date must be checked in the source.
275-10-05Overview and Background
Source downloaded: .Record version f2e4f28bd235. Effective date must be checked in the source.
- a The nature of the entity's operations, including the activities in which the entity is currently engaged if principal operations have not commenced
- b The use of estimates in the preparation of the entity's financial statements
- c Significant concentrations in certain aspects of the entity's operations.
Nature of Operations
Use of Estimates in the Preparation of Financial Statements
Current Vulnerability Due to Certain Concentrations
275-10-10Objectives
Source downloaded: .Record version 1998405dc186. Effective date must be checked in the source.
275-10-15Scope and Scope Exceptions
Source downloaded: .Record version 0aa5b0e4cd7f. Effective date must be checked in the source.
Overall Guidance
Entities
Other Considerations
- aManagement or key personnel
- bProposed changes in government regulations
- cProposed changes in accounting principles
- dDeficiencies in the internal control structure
- eThe possible effects of acts of God, war, or sudden catastrophes.
275-10-50Disclosure
Source downloaded: .Record version c903ccece4bd. Effective date must be checked in the source.
- a Nature of operations , including the activities in which the entity is currently engaged if principal operations have not commenced
- b Use of estimates in the preparation of financial statements
- c Certain significant estimates
- d Current vulnerability due to certain concentrations.
Nature of Operations/Activities
Use of Estimates in the Preparation of Financial Statements
Certain Significant Estimates
- a It is at least reasonably possible that the estimate of the effect on the financial statements of a condition, situation, or set of circumstances that existed at the date of the financial statements will change in the near term due to one or more future confirming events.
- b The effect of the change would be material to the financial statements.
- a If an estimate (including estimates that involve contingencies covered by Topic 450) meets the criteria for disclosure under paragraph 275-10-50-8, this Subtopic requires disclosure of an indication that it is at least reasonably possible that a change in the estimate will occur in the near term; Topic 450 does not distinguish between near-term and long-term contingencies.
- b An estimate that does not involve a contingency covered by Topic 450, such as estimates associated with long-term operating assets and amounts reported under profitable long-term contracts, may meet the criteria in paragraph 275-10-50-8. This Subtopic requires disclosure of the nature of the estimate and an indication that it is at least reasonably possible that a change in the estimate will occur in the near term.
- a Inventory subject to rapid technological obsolescence
- b Specialized equipment subject to technological obsolescence
- c Valuation allowances for deferred tax assets based on future taxable income
- d Capitalized motion picture film production costs
- e Capitalized computer software costs
- f Deferred policy acquisition costs of insurance entities
- g Valuation allowances for commercial and real estate loans
- h Environmental remediation-related obligations
- i Litigation-related obligations
- j Contingent liabilities for obligations of other entities
- k Amounts reported for long-term obligations, such as amounts reported for pensions and postemployment benefits
- l Estimated net proceeds recoverable, the provisions for expected loss to be incurred, or both, on disposition of a business or assets
- m Amounts reported for long-term contracts.
- a A change in the useful life of an intangible
- b A change in the expected likelihood of renewal or extension of an intangible asset.
Current Vulnerability Due to Certain Concentrations
- a The concentration exists at the date of the financial statements.
- b The concentration makes the entity vulnerable to the risk of a near-term severe impact.
- c It is at least reasonably possible that the events that could cause the severe impact will occur in the near term.
- a Concentrations in the volume of business transacted with a particular customer, supplier, lender, grantor, or contributor. The potential for the severe impact can result, for example, from total or partial loss of the business relationship. For purposes of this Subtopic, it is always considered at least reasonably possible that any customer, grantor, or contributor will be lost in the near term.
- b Concentrations in revenue from particular products, services, or fund-raising events. The potential for the severe impact can result, for example, from volume or price changes or the loss of patent protection for the particular source of revenue.
- c Concentrations in the available sources of supply of materials, labor, or services, or of licenses or other rights used in the entity's operations. The potential for the severe impact can result, for example, from changes in the availability to the entity of a resource or a right.
- d Concentrations in the market or geographic area in which an entity conducts its operations. The potential for the severe impact can result, for example, from negative effects of the economic and political forces within the market or geographic area. For purposes of this Subtopic, it is always considered at least reasonably possible that operations located outside an entity's home country will be disrupted in the near term.
- a For labor subject to collective bargaining agreements, disclosure shall include both the percentage of the labor force covered by a collective bargaining agreement and the percentage of the labor force covered by a collective bargaining agreement that will expire within one year.
- b For operations located outside the entity's home country, disclosure shall include the carrying amounts of net assets and the geographic areas in which they are located.
Application of Disclosure Criteria
275-10-55Implementation Guidance and Illustrations
Source downloaded: .Record version 37696d8d247e. Effective date must be checked in the source.
Illustrations
- Conglomerate, Inc. is a multinational manufacturer and engineering concern. The entity's principal lines of business are automotive products, aerospace products and technologies, textiles, and nonprescription health-care products, all of which are about equal in size based on sales. The principal markets for the automotive and aerospace products and technologies are European- and Far East-based industrial concerns. Textiles are sold primarily to domestic clothing manufacturers, while nonprescription health-care products are sold primarily to wholesale and retail distributors worldwide.
- aInformation necessary for users not familiar with the operations of Conglomerate to identify and consider the broad risks and uncertainties associated with the businesses and markets in which it operates and competes. From the disclosures provided, financial statement users having a general knowledge of business matters should be able to assess that Conglomerate's product lines are subject to different and varied risks. Those financial statement users familiar with the businesses recognize the general risks associated with each of these businesses and their related markets.
- bInformation that facilitates the overall understanding of the financial information presented. This kind of disclosure could provide users with a basis for comparing an entity's financial information with that of competitors or with applicable industry statistics.
- cInsight into the location of Conglomerate's principal markets, although on a broad scale. Because Conglomerate's markets are so diverse, it likely would not be useful to enumerate the specific locations of the entity's markets. For this reason, the manner in which the information is disclosed in the illustrative disclosure is sufficient to meet the broad objectives of this Subtopic.
- NewCompany, Inc. (Company) is a business whose planned principal operations are the design, engineering, and manufacturing of air quality test equipment. The Company is currently conducting research and development activities to operationalize certain patented technology that the Company owns so it can manufacture rapid-result test kits for certain airborne contaminants in high-risk environments.
- During the last year, the Company secured a research facility in Norwalk, Connecticut, which houses all of its employees and research and development activities. The Company also is in the process of raising additional equity capital to support the completion of its development activities to begin manufacturing the test kits as soon as possible.
- The Company's activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company's current technology before another company develops similar technology and test kits.
- aInformation necessary for financial statement users not familiar with the activities of the Company to identify and consider the broad risks and uncertainties associated with businesses that have activities that are similar to those in which the Company is engaged. From the disclosures provided, financial statement users that have a general knowledge of business matters should be able to assess both of the following:
- 1That the Company's activities are subject to different and varied risks, including the risk that the entity may be affected by the rapidly changing and intensely competitive technology market
- 2That the Company is dependent on additional capital resources for the continuation and expansion of its business activities.
- 1
- bInformation that facilitates the overall understanding of the financial information provided. That kind of disclosure could provide users with a basis for understanding the Company's financial information and comparing that information with similar entities or other relevant statistics.
- Smith Corporation is engaged principally in the design, engineering, and manufacturing of military aircraft and related peripheral equipment for sale primarily to the U.S. government.
- aInformation needed by users who are not familiar with the operations of Smith Corporation to identify and consider the broad risks and uncertainties faced by all or most entities operating in a specific business or market, which in this case is the defense contracting business. From this disclosure, financial statement users having a general knowledge of business matters should know that Smith's business may be heavily affected by future changes in U.S. defense and foreign policies.
- bInformation that aids in the overall understanding of the other financial information presented. Certain accounting procedures involving estimation may apply only to particular industries or may be relevant in comparing a business entity's financial statements with those of business entities in other industries.
- cInsight into the location of Smith's principal product markets and information about its current vulnerability due to concentrations. Users would be able to recognize and assess Smith's dependency on sales to the U.S. government (assuming the loss of the government as a customer would result in a near-term severe impact to Smith Corporation).
- The preparation of financial statements in conformity with generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
- The entity currently buys all of its integrated circuits, an important component of its products, from one supplier. Although there are a limited number of manufacturers of the particular integrated circuits, management believes that other suppliers could provide similar integrated circuits on comparable terms. A change in suppliers, however, could cause a delay in manufacturing and a possible loss of sales, which would affect operating results adversely.
- Felt Pharmaceutical Company is a national pharmaceutical manufacturer with sales throughout the United States. The patent on one of its major products expires next year. This product accounts for approximately one-third [or "a significant portion"] of the entity's revenues and a higher percentage of its gross profit.
- Included in the entity's consolidated balance sheet at December 31, 20X4, are the net assets of the entity's manufacturing operations, all of which are located in a single facility in Switzerland and which total approximately $20 million.
275-10-60Relationships
Source downloaded: .Record version 296ca246fe6e. Effective date must be checked in the source.